Video

Best Practices in Defining and Aggregating Study Data for Oversight

In a recent Tufts CSDD survey of global sponsors on Oversight, Clinical Operations executives called out “improving study and CRO performance and productivity” as top priorities. In order to achieve these goals, they need to assess both portfolio and study data accurately and efficiently.
In this demo, Linda Sullivan of Metrics Champion Consortium and Comprehend discuss recent metrics research that uncovered how various aggregation styles and views of study-level data can be used to monitor portfolio-level plans and timelines.  They also discuss both advantages and disadvantages of various study data views, and ways in which Sponsors can evaluate study data collaboratively with their vendor partners.

Additionally, a demonstration is given of how leading sponsors can easily aggregate and manage study data using purpose-built automation. With real-time, accurate dashboards and metrics, sponsors can increase their speed to a quality result.

Access Out-of-the-Box Features in 4 Weeks—Guaranteed.

Saama can put you on the fast track to clinical trial process innovation.